Siga Technologies INC Liabilities Subject to Compromise, Expense (Income) Items (Deprecated 2016-01-31)
Siga Technologies INC (SIGA) had Liabilities Subject to Compromise, Expense (Income) Items (Deprecated 2016-01-31) of $684.00 thousand as of 2016-04-12, per its 10-K filed 2017-03-07.
Discontinued › Notes
us-gaap:LiabilitiesSubjectToCompromiseExpenseIncomeItems · last filed 2017-03-07
- 2016-04-12: Liabilities Subject to Compromise, Expense (Income) Items (Deprecated 2016-01-31) $684.00K.
| Period end | Liabilities Subject to Compromise, Expense (Income) Items (Deprecated 2016-01-31) |
|---|---|
| 2016-04-12 | $684.00K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |